Actinogen Medical Limited (ASX:ACW)
Australia flag Australia · Delayed Price · Currency is AUD
0.0410
-0.0010 (-2.38%)
At close: Mar 9, 2026

Actinogen Medical Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
147731667390216
Upgrade
Market Cap Growth
14.14%-56.07%128.98%-19.08%-58.41%779.06%
Upgrade
Enterprise Value
140501555868203
Upgrade
Last Close Price
0.040.020.060.040.050.12
Upgrade
PS Ratio
19.9113.3116.7514.8624.67108.80
Upgrade
PB Ratio
17.523.998.455.424.1312.37
Upgrade
P/TBV Ratio
21.744.419.456.614.7214.97
Upgrade
EV/Sales Ratio
19.059.2015.6011.9318.61102.47
Upgrade
Debt / Equity Ratio
0.030.180.020.010.010.01
Upgrade
Net Debt / Equity Ratio
-0.75-0.72-0.46-0.62-0.74-0.76
Upgrade
Net Debt / EBITDA Ratio
0.350.880.710.791.763.67
Upgrade
Net Debt / FCF Ratio
0.381.740.540.961.707.64
Upgrade
Asset Turnover
0.410.240.540.250.180.13
Upgrade
Quick Ratio
4.173.7413.836.9913.7319.87
Upgrade
Current Ratio
4.193.7613.917.0413.8019.99
Upgrade
Return on Equity (ROE)
-110.77%-77.47%-78.81%-61.18%-48.46%-27.62%
Upgrade
Return on Assets (ROA)
-63.83%-41.91%-45.37%-35.65%-28.59%-16.16%
Upgrade
Return on Capital Employed (ROCE)
-216.20%-82.90%-66.40%-81.90%-43.70%-22.20%
Upgrade
Earnings Yield
-12.22%-20.16%-7.84%-14.80%-10.58%-1.81%
Upgrade
FCF Yield
-11.22%-10.39%-10.20%-12.02%-10.60%-0.80%
Upgrade
Buyback Yield / Dilution
-19.05%-37.04%-20.69%-4.92%-22.20%-25.69%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.